Showing results (381-390 of 454) with videos related to
Sort By:
Pageof 46
Breast Cancer Research and Treatment|July 29, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective studyGuido Maria Giuffrè, Luisa Carbognin, Giovanna Masone Iacobucci, et al.Oncotarget|November 7, 2015
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysisPatrizia Vici, Anna Di Benedetto, Cristiana Ercolani, et al.Breast (Edinburgh, Scotland)|June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validationLuisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.Journal of Personalized Medicine|August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast CancerFabio Marazzi, Valeria Masiello, Armando Orlandi, et al.Oncology|December 7, 2021
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?Alessandra Fabi, Mariangela Ciccarese, Sinome Scagnoli, et al.Journal of Personalized Medicine|December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient SeriesArmando Orlandi, Elena Iattoni, Laura Pizzuti, et al.Neuro-Oncology|October 22, 2022
Palliative care and end-of-life care in adults with malignant brain tumorsJohan A F Koekkoek, Pim B van der Meer, Andrea Pace, et al.Acta Oncologica (Stockholm, Sweden)|May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohortFabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.NPJ Precision Oncology|January 22, 2025
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab DeruxtecanAlessandra Fabi, Alessandro Rossi, Roberta Caputo, et al.European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial)Giuseppe Lombardi, Paola Del Bianco, Alba A Brandes, et al.Pageof 46